Filing Details

Accession Number:
0001209191-18-045516
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-08-06 16:16:33
Reporting Period:
2018-08-02
Accepted Time:
2018-08-06 16:16:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1180262 Herbalife Nutrition Ltd. HLF Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1624527 L Alan Hoffman 800 W. Olympic Blvd
Suite 406
Los Angeles CA 90015
Evp, Global Corporate Affairs No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-08-02 55,576 $57.50 3,764 No 4 S Direct
Common Stock Acquisiton 2018-08-02 26,512 $15.22 30,276 No 4 M Direct
Common Stock Disposition 2018-08-02 6,991 $57.74 23,285 No 4 D Direct
Common Stock Disposition 2018-08-02 9,681 $57.74 13,604 No 4 F Direct
Common Stock Acquisiton 2018-08-02 8,734 $31.26 22,338 No 4 M Direct
Common Stock Disposition 2018-08-02 4,728 $57.74 17,610 No 4 D Direct
Common Stock Disposition 2018-08-02 1,987 $57.74 15,623 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 D Direct
No 4 F Direct
No 4 M Direct
No 4 D Direct
No 4 F Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Appreciation Rights Disposition 2018-08-02 26,512 $0.00 26,512 $15.22
Common Stock Stock Appreciation Rights Disposition 2018-08-02 8,734 $0.00 8,734 $31.26
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
26,504 2018-03-02 2025-03-02 No 4 M Direct
26,200 2026-05-09 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2018.
  2. On May 14, 2018, the common stock of Herbalife Nutrition Ltd. split 2-for-1, resulting in the reporting person's acquisition of 29,670 additional shares of common stock.
  3. The reporting person received 9,840 shares of common stock upon the net exercise of 26,512 stock appreciation rights ("SARS"). The reporting person forfeited 6,991 shares of common stock underlying the SARS in payment of the exercise price and 9,681 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on August 2, 2018 of $57.74.
  4. The reporting person received 2,019 shares of common stock upon the net exercise of 8,734 SARS. The reporting person forfeited 4,728 shares of common stock underlying the SARS in payment of the exercise price and 1,987 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on August 2, 2018 of $57.74.
  5. These SARS were previously reported as covering 53,017 shares at an exercise price of $30.44 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018.
  6. These SARS were previously reported as covering 21,834 shares at an exercise price of $62.51 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018.
  7. On May 9, 2016, the reporting person was granted 43,668 (post-split) Stock Appreciation Rights (SARs). These SARs vested 20% on May 9, 2017, 20% on May 9, 2018, and the remaining 60% will vest on May 9, 2019.